Host: |
HEK293 cells |
Reactivity: |
Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Recombinant-Mouse GITR Ligand/TNFSF18-N-hFC protein was developed from hek293 cells and has a target region of N-hFC. For use in research applications. |
Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
Tnfsf18 |
Gene ID: |
240873 |
Uniprot ID: |
TNF18_MOUSE |
Immunogen Region: |
Thr47-Ser173 |
Immunogen: |
Recombinant Mouse GITR Ligand/TNFSF18 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Thr47-Ser173) of mouse GITR Ligand/TNFSF18 (Accession #NP_899247.3) fused with a hFc tag at the N-terminus. |
Post Translational Modifications | N-glycosylated. |
Function | Cytokine that binds to TNFRSF18/AITR/GITR. Regulates T-cell responses. Can function as costimulator and lower the threshold for T-cell activation and T-cell proliferation. Important for interactions between activated T-lymphocytes and endothelial cells. Mediates activation of NF-kappa-B. Triggers increased phosphorylation of STAT1 and up-regulates expression of VCAM1 and ICAM1. Promotes leukocyte adhesion to endothelial cells. Regulates migration of monocytes from the splenic reservoir to sites of inflammation. |
Protein Name | Tumor Necrosis Factor Ligand Superfamily Member 18Gitr LigandGitrlGlucocorticoid-Induced Tnf-Related Ligand |
Database Links | Reactome: R-MMU-5669034 |
Cellular Localisation | Cell MembraneSingle-Pass Type Ii Membrane Protein |
Alternative Protein Names | Tumor Necrosis Factor Ligand Superfamily Member 18 proteinGitr Ligand proteinGitrl proteinGlucocorticoid-Induced Tnf-Related Ligand proteinTnfsf18 proteinGitrl protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance